Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy

Surgery, 04/20/2012

Authors demonstrated the potent therapeutic effects of a novel tumor–specific conditionally replicative IFN–expressing adenovirus. With potential to locally deliver IFN and avoid systemic toxicity, this strategy may therefore expand the application of this robust and promising therapy.

Print Article Summary Cat 2 CME Report